Analystreport

Amphastar Pharmaceuticals (NASDAQ:AMPH) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.

Amphastar Pharmaceuticals, Inc.  (AMPH) 
Last amphastar pharmaceuticals, inc. earnings: 3/12 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.amphastar.com/investor-relations